Valerio Guarente
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.
Journal: Hematological oncology
Published: September 02, 2025
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.
Journal: HemaSphere
Published: May 14, 2024
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
Journal: EClinicalMedicine
Published: July 31, 2023
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.
Journal: British journal of haematology
Published: September 29, 2022
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Journal: American journal of hematology
Published: January 20, 2022
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.
Journal: Frontiers in oncology
Published: June 22, 2021
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Journal: International journal of molecular sciences
Published: May 14, 2021
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status.
Journal: Frontiers in oncology
Published: February 16, 2021
Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL.
Journal: Cancers
Published: January 23, 2021
Last Updated: 09/26/2026